Cigna: Repeated Earnings Beats, But The Market Remains Skeptical

AI Briefing

• – Cigna delivers another quarter of strong revenue and EPS beats, but the market remains skeptical about its valuation.
• – CI stock is undervalued versus sector peers, making it a potential buy opportunity.
• – Despite earnings beats, Cigna's stock price has not reflected its underlying financial performance.